Drug Shortage Report for PRIORIX-TETRA
| Report ID | 69657 |
| Drug Identification Number | 02297884 |
| Brand name | PRIORIX-TETRA |
| Common or Proper name | Combined measles, mumps, rubella and varicella vaccine, live, attenuated |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 10's |
| ATC code | J07BD |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-12-13 |
| Estimated end date | 2019-02-04 |
| Actual end date | 2019-01-17 |
| Shortage status | Resolved |
| Updated date | 2019-01-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-01-18 | French | Compare |
| v4 | 2019-01-18 | English | Compare |
| v3 | 2018-12-14 | French | Compare |
| v2 | 2018-12-14 | French | Compare |
| v1 | 2018-12-14 | English | Compare |
Showing 1 to 5 of 5